sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> antibacterial drug market

report

Antibacterial Drug Market, by Drug Origin (Synthetic, Semi-Synthetic, Natural), Chemical Class (Beta-Lactam, Aminoglycosides, Quinolones, Tetracycline, Macrolides, Phenicols, Folate Antagonist), Spectrum Of Activity (Narrow Spectrum and Broad Spectrum Antibodies), Mechanism of Action (Bactericides and Bacteriostatics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC127 October 2016 100+ FREE 10% CUSTOMIZATION

The global antibacterial drug market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges in the antibacterial drug market.

KEY BENEFITS OF THE REPORT

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The increasing prevalence of infectious diseases around the world is one of the major driving factors for the global antibacterial drug market.
  • Apart from that, a significant rise in the government funding for the research and development activities is also one of the key factors driving the growth of the antibacterial drug market during the forecast period.
  • However, the increasing drug resistance and patent expirations are the major restraints for the market growth during the forecast period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s antibacterial drug market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

The market is segmented into bactericidal and bacteriostatic to know about the assumption considered for the study. Download PDF brochure.

MARKET SEGMENTATION

This report analyzes the antibacterial drug market by the following segments:

  • Antibacterial Drug Market, by Drug Origin
    • Synthetic
    • Semi-Synthetic
    • Natural
  • Antibacterial Drug Market, by Chemical Class
    • Beta Lactam
    • Aminoglycosides
    • Quinolones
    • Tetracycline
    • Macrolides
    • Phenicols
    • Folate Antagonist
  • Antibacterial Drug Market, by Spectrum Of Activity
    • Narrow Spectrum
    • Broad Spectrum Antibodies
  • Antibacterial Drug Market, by Mechanism Of Action
    • Bactericides
    • Bacteriostatics

KEY MARKET PLAYERS

Key players in the antibacterial drug market include:

  • Pfizer Inc.
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Bayer AG
  • Sanofi
  • AstraZeneca plc
  • Allergan
  • GlaxoSmithKline Plc
  • Forest Laboratories, Inc.
  • Eli Lilly & Company
  • Bristol-Meyer Squibb Company

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

Antibacterial Drug Market

TRENDING RELATED REPORT

Prescription Pharmaceuticals Market, by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Pricing Analysis
    3. Regulatory Analysis
    4. Reimbursement Landscape
  5. ANTIBACTERIAL DRUG MARKET, BY DRUG ORIGIN
    1. Segment Share
    2. By Drug Origin
      1. Synthetic
      2. Semi-Synthetic
      3. Natural
  6. ANTIBACTERIAL DRUG MARKET, BY CHEMICAL CLASS
    1. Segment Share
    2. By Chemical Class
      1. Beta Lactam
      2. Aminoglycosides
      3. Quinolones
      4. Tetracycline
      5. Macrolides
      6. Phenicols
      7. Folate Antagonist
  7. ANTIBACTERIAL DRUG MARKET, BY SPECTRUM OF ACTIVITY
    1. Segment Share
    2. By Spectrum of Activity
      1. Narrow Spectrum
      2. Broad Spectrum Antibodies
  8. ANTIBACTERIAL DRUG MARKET, BY MECHANISM OF ACTION
    1. Segment Share
    2. By Mechanism of Action
      1. Bactericides
      2. Bacteriostatics
  9. ANTIBACTERIAL DRUG MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Drug Origin
      3. By Chemical Class
      4. By Spectrum of Activity
      5. By Mechanism of Action
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Drug Origin
      3. By Chemical Class
      4. By Spectrum of Activity
      5. By Mechanism of Action
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Drug Origin
      3. By Chemical Class
      4. By Spectrum of Activity
      5. By Mechanism of Action
    4. Rest of the World
      1. By Country
        1. Latin America
        2. Middle East & Africa
      2. By Drug Origin
      3. By Chemical Class
      4. By Spectrum of Activity
      5. By Mechanism of Action
  10. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovator Companies
  11. KEY MARKET PLAYERS
    1. Pfizer Inc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Johnson and Johnson
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Bayer AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Sanofi
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. AstraZeneca
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Allergan
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. GlaxoSmithKline plc
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Forest Laboratories, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    11. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    12. Bristol-Myers Squibb Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us